Liver fibrosis is characterized by the excessive accumulation of extracellular matrix (ECM) and is a risk factor for liver cancer.
This study investigated the anti-fibrotic effect of the Wnt/Î²-catenin signalling inhibitor HC-1 in human hepatic stellate cells and a mouse liver fibrosis model.
